Expert guidance, every step. Medical solutions personalized, simplified.

RU
Меню

A vaccine for advanced prostate cancer

VACCINES FROM PROSTATE CANCER— NEW CLINICAL TRIAL

Patients with prostate cancer who have surgery is indicated for prostate removal can now participate in a Phase II clinical trial of a prostate cancer vaccine.

If you’re surgery is not indicated and you only have prostate cancer in the early stages of the disease, when the cancer cells have not yet spread outside the prostate gland. Then vaccines have already been produced for such patients and they are being used successfully. Read about it in the article «Early prostate cancer vaccine». We will also organize an effective treatment for you!

Place of the study: State University Hospital.

Prostate cancer vaccine late in the process — is a new type of vaccine. The vaccine activates the immune system to make it attack certain proteins that are almost exclusively found in prostate cancer cells.

The use of a vaccine to treat cancer is based on the principle that the body’s own immune system can be stimulated to fight certain cells in the body in the same way it normally fights «foreign» objects such as bacteria or viruses. The vaccine is designed to support the body’s own immune system in identifying and destroying prostate cancer cells.

What is the purpose of the clinical trial?

The purpose of the clinical trial is to test whether the prostate cancer vaccine has an effect on the tumor and how well it is tolerated.

What are the prerequisites for participation?

You can take part in this study if you have

  • prostate cancer with a high or intermediate risk of recurrence has been diagnosed
  • is indicated for prostate surgery

Make an appointment

    By clicking this button, you agree to the processing of personal data